Yatharth Hospital & Trauma Care Services (YATHARTH) — Financial Results

📢 Key Event
Yatharth Hospital reported record Q1 FY27 financial results and operational updates.

🔄 What Changed
Revenue grew 51% YoY to ₹3,927 crores; EBITDA rose 39% YoY to ₹917 crores; adjusted EBITDA margin reached 28.1%; new hospitals contributed 27% to revenue mix; Faridabad Sector-20 achieved EBITDA breakeven in 9 months; first interim dividend of 5% announced; ESOP Scheme 2026 launched.

🔮 What's Next
Target of 5,000+ beds by FY28; Gurugram hospital expected operational by Q1 FY28; ongoing expansion in Noida Extension, Greater Noida, Agra, and Jhansi; specialty services and payer mix diversification to drive ARPOB growth.

💡 Investor Takeaway
The company is executing a scalable cluster-based expansion model with strong margin and occupancy trends, supported by strategic investments and operational milestones.

Yatharth Hospital reported record Q1 FY27 revenue of ₹3,927 crores (+51% YoY, +15% QoQ) and EBITDA of ₹917 crores (+39% YoY, +15% QoQ), with adjusted EBITDA margin at 28.1%. PAT stood at ₹454 crores, driven by new hospitals contributing 27% to revenue mix and Faridabad Sector-20 achieving EBITDA breakeven in 9 months. The company launched its 2026 ESOP Scheme, announced a 5% interim dividend, and advanced ESG initiatives. Operational highlights include Agra Hospital’s 20% EBITDA margin in its first full quarter and Gurugram hospital construction progressing toward Q1 FY28 operationalization. The investor presentation underscores a cluster-based expansion strategy targeting 5,000+ beds by FY28, with 15 hospitals now operational and specialty services like oncology and robotics boosting ARPOB to Rs 35K. Occupancy reached 91%, and revenue growth was fueled by payer mix diversification and JCI/NABH accreditations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — YATHARTH ✨ Ask AI About This

About Yatharth Hospital & Trauma Care Services Limited (YATHARTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹7,858.66 Cr P/E: 52.5

View full YATHARTH stock details →

📡 Get AI alerts when YATHARTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track YATHARTH — Free

💡 Ask AI about this filing

"What is the valuation multiple relative to peers like Apollo Hospitals?" "How does ARPOB growth compare to industry benchmarks?" "When will Gurugram hospital contribute to profitability?"

Ask AI Free →

📊 More YATHARTH filings

See all YATHARTH filings →

🔥 Also filed on 11 August 2026

ULTRACEMCO UltraTech Cement Limited Announcement SUDEEPPHRM Sudeep Pharma Limited Financial Results SUTLEJTEX Sutlej Textiles and Industries Limited Financial Results RBZJEWEL RBZ Jewellers Limited Financial Results TATVA Tatva Chintan Pharma Chem Limited Corporate Action AETHER Aether Industries Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when YATHARTH files new disclosures

Track YATHARTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.